hmm... ann looks good to me, super strong growth in revenue and decent growth in NPAT even with a hit for depreciation...market seems to not like this tho...???any thoughts?
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game